Does TOZINAMERAN Cause Malignant neoplasm progression? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Malignant neoplasm progression have been filed in association with TOZINAMERAN. This represents 0.1% of all adverse event reports for TOZINAMERAN.
5
Reports of Malignant neoplasm progression with TOZINAMERAN
0.1%
of all TOZINAMERAN reports
4
Deaths
5
Hospitalizations
How Dangerous Is Malignant neoplasm progression From TOZINAMERAN?
Of the 5 reports, 4 (80.0%) resulted in death, 5 (100.0%) required hospitalization, and 3 (60.0%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOZINAMERAN. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does TOZINAMERAN Cause?
Fatigue (1,197)
Headache (904)
Covid-19 (896)
Pain in extremity (675)
Pyrexia (665)
Pain (633)
Drug ineffective (547)
Nausea (473)
Arthralgia (464)
Off label use (446)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which TOZINAMERAN Alternatives Have Lower Malignant neoplasm progression Risk?
TOZINAMERAN vs TRABECTEDIN
TOZINAMERAN vs TRACLEER
TOZINAMERAN vs TRADJENTA
TOZINAMERAN vs TRALOKINUMAB-LDRM
TOZINAMERAN vs TRAMADOL